SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
RFK Jr. releases new dietary guidelines with emphasis on protein, full-fat dairy - 2Merz visit highlights new strategic, and strained, Germany-Israel bond
- 3Underestimated Metropolitan Experience Urban communities On the planet
- 4Telescope in Chile captures stunning new picture of a cosmic butterfly
- 5Audits of 6 European Busssiness Class Flights
- CDC studies show value of nationwide wastewater disease surveillance, as potential funding cut looms
- 6 Well known Nissan Vehicles in the U.S.
- 'The Boys' Season 5 premiere: How to watch for less, what to know about the final series and more
- Mexican Woman Accused of Assaulting Partner With Belt After He Refused Sex, Police Say
- Explainer-Why are hepatitis B vaccines given to newborns?
- Step by step instructions to Pick the Right Dental specialist for Your Teeth Substitution
- Most loved Specially prepared Espresso Mix: Which Meal Do You Adore the Most?
- I'm an 83-year-old yoga instructor. I'm not your typical grandma — I still work to feel fulfilled and supplement my Social Security.
- Regeneron's experimental therapy combo effective in untreated cancer patients
